CCN2 (Cellular Communication Network factor 2) in the bone marrow microenvironment, normal and malignant hematopoiesis
Open Access
- 11 January 2021
- journal article
- review article
- Published by Wiley in Journal of Cell Communication and Signaling
- Vol. 15 (1) , 25-56
Abstract
CCN2, formerly termed Connective Tissue Growth Factor, is a protein belonging to the Cellular Communication Network (CCN)-family of secreted extracellular matrix-associated proteins. As a matricellular protein it is mainly considered to be active as a modifier of signaling activity of several different signaling pathways and as an orchestrator of their cross-talk. Furthermore, CCN2 and its fragments have been implicated in the regulation of a multitude of biological processes, including cell proliferation, differentiation, adhesion, migration, cell survival, apoptosis and the production of extracellular matrix products, as well as in more complex processes such as embryonic development, angiogenesis, chondrogenesis, osteogenesis, fibrosis, mechanotransduction and inflammation. Its function is complex and context dependent, depending on cell type, state of differentiation and microenvironmental context. CCN2 plays a role in many diseases, especially those associated with fibrosis, but has also been implicated in many different forms of cancer. In the bone marrow (BM), CCN2 is highly expressed in mesenchymal stem/stromal cells (MSCs). CCN2 is important for MSC function, supporting its proliferation, migration and differentiation. In addition, stromal CCN2 supports the maintenance and longtime survival of hematopoietic stem cells, and in the presence of interleukin 7, stimulates the differentiation of pro-B lymphocytes into pre-B lymphocytes. Overexpression of CCN2 is seen in the majority of B-acute lymphoblastic leukemias, especially in certain cytogenetic subgroups associated with poor outcome. In acute myeloid leukemia, CCN2 expression is increased in MSCs, which has been associated with leukemic engraftment in vivo. In this review, the complex function of CCN2 in the BM microenvironment and in normal as well as malignant hematopoiesis is discussed. In addition, an overview is given of data on the remaining CCN family members regarding normal and malignant hematopoiesis, having many similarities and some differences in their function.Keywords
This publication has 359 references indexed in Scilit:
- MicroRNAs 130a/b are regulated by BCR-ABL and downregulate expression of CCN3 in CMLJournal of Cell Communication and Signaling, 2011
- CCN3/CCN2 regulation and the fibrosis of diabetic renal diseaseJournal of Cell Communication and Signaling, 2010
- Regulation of pro‐inflammatory and pro‐fibrotic factors by CCN2/CTGF in H9c2 cardiomyocytesJournal of Cell Communication and Signaling, 2010
- Thrombopoietic‐mesenchymal interaction that may facilitate both endochondral ossification and platelet maturation via CCN2Journal of Cell Communication and Signaling, 2009
- Matricellular proteins: an overviewJournal of Cell Communication and Signaling, 2009
- CCN3: a key growth regulator in Chronic Myeloid LeukaemiaJournal of Cell Communication and Signaling, 2009
- Expression of CCN family of genes in human skin in vivo and alterations by solar-simulated ultraviolet irradiationJournal of Cell Communication and Signaling, 2009
- Proteins on the catwalk: modelling the structural domains of the CCN family of proteinsJournal of Cell Communication and Signaling, 2009
- Connective tissue growth factor (CTGF, CCN2) gene regulation: a potent clinical bio‐marker of fibroproliferative disease?Journal of Cell Communication and Signaling, 2009
- Connective tissue growth factor with a novel fibronectin binding site promotes cell adhesion and migration during rat oval cell activationHepatology, 2008